Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CoverEdge Algorithm Programming Study

Not Applicable

Completed

Conditions: Chronic Pain

First Posted Date: 2015-07-09

Last Posted Date: 2022-11-04

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT02492880

Locations: 🇺🇸
Barolat Neuroscience, Denver, Colorado, United States
🇺🇸
Albany Medical Center, Albany, New York, United States

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE Japan)

Not Applicable

Completed

Conditions: Aortic Stenosis

Interventions: Device: Lotus Valve System

First Posted Date: 2015-07-08

Last Posted Date: 2021-09-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 70

Registration Number: NCT02491255

Locations: 🇯🇵
Shonankamakura General Hospital, Kamakura, Kanagawa, Japan
🇯🇵
Kurashiki Central Hospital, Kurashiki, Okayama, Japan
🇯🇵
Osaka University Hospital, Suita, Osaka, Japan

and more 2 locations

Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)

Completed

Conditions: Post Market Surveillance Study Following Clinical Routine

Interventions: Device: CRT-P indicated patients

First Posted Date: 2015-07-02

Last Posted Date: 2019-09-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 64

Registration Number: NCT02488239

Locations: 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
🇫🇮
Tampere University Hospital, Tampere, Finland
🇩🇪
Unfallkrankenhaus Berlin, Berlin, Germany

and more 5 locations

The Captivator EMR Registry

Completed

Conditions: Barrett's Esophagus

First Posted Date: 2015-06-26

Last Posted Date: 2018-03-07

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 291

Registration Number: NCT02482701

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇧🇪
University Hospital Leuven, Leuven, Belgium
🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada

and more 9 locations

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

Phase 1

Terminated

Conditions: Glioma

Interventions: Procedure: CM-BC2 Irinotecan drug-eluting bead

First Posted Date: 2015-06-25

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 5

Registration Number: NCT02481960

Locations: 🇫🇷
Centre Hopsitalier Universitaire d'Angers, Angers, France
🇩🇪
Prof. Erol Sandalcioglu, Hannover, Germany

FAST Feasibility Study

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: Boston Scientific Fully Absorbable Scaffold

First Posted Date: 2015-06-12

Last Posted Date: 2022-06-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 33

Registration Number: NCT02470884

Locations: 🇦🇺
The Prince Charles Hospital, Chermside, Queensland, Australia
🇦🇺
St. Vincent's Hospital, Fitzroy, Victoria, Australia
🇦🇺
Peninsula Health, Frankston, Victoria, Australia

and more 4 locations

COMFORT: A Multicenter, Open-label, Randomized, Crossover Study

Phase 4

Completed

Conditions: Varicose Veins

Interventions: Drug: Varithena®
Device: Radiofrequency ablation

First Posted Date: 2015-06-04

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 35

Registration Number: NCT02462720

Locations: 🇺🇸
Coastal Vascular and Interventional, PLLC, Pensacola, Florida, United States
🇺🇸
Midwest Institute for Minimally Invasive Therapies, Melrose Park, Illinois, United States
🇺🇸
Venous Institute of Buffalo, Amherst, New York, United States

and more 1 locations

A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

Phase 3

Terminated

Conditions: Hepatoma
Hepatocellular Carcinoma
Liver Cell Carcinoma

Interventions: Device: DEB-TACE
Drug: Sorafenib

First Posted Date: 2015-06-03

Last Posted Date: 2021-02-12

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2

Registration Number: NCT02460991

Locations: 🇺🇸
University of Alabama Hospital, Birmingham, Alabama, United States
🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
University of Louisville, Louisville, Kentucky, United States

and more 3 locations

Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.

Phase 1

Terminated

Conditions: Glioma

Interventions: Procedure: CM-BC2

First Posted Date: 2015-05-05

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 9

Registration Number: NCT02433392

Locations: 🇬🇧
Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

Not Applicable

Completed

Conditions: Ventricular Fibrillation
Ventricular Tachycardia
Low Cardiac Output

Interventions: Device: EMBLEM S-ICD System

First Posted Date: 2015-05-05

Last Posted Date: 2025-03-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1173

Registration Number: NCT02433379

Locations: 🇺🇸
Alabama Cardiovascular Group, Birmingham, Alabama, United States
🇺🇸
Huntsville Hospital - The Heart Center, PC, Huntsville, Alabama, United States
🇺🇸
Mercy Gilbert Medical Center, Gilbert, Arizona, United States

and more 106 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy